Operative hysteroscopy versus vacuum aspiration for incomplete spontaneous abortion (HY-PER): study protocol for a randomized controlled trial

Cyrille Huchon, Martin Koskas, Aubert Agostini, Cherif Akladios, Souhail Alouini, Estelle Bauville, Nicolas Bourdel, Hervé Fernandez, Xavier Fritel, Olivier Graesslin, Guillaume Legendre, Jean-Philippe Lucot, Isabelle Matheron, Pierre Panel, Cyril Raiffort, Arnaud Fauconnier, Cyrille Huchon, Martin Koskas, Aubert Agostini, Cherif Akladios, Souhail Alouini, Estelle Bauville, Nicolas Bourdel, Hervé Fernandez, Xavier Fritel, Olivier Graesslin, Guillaume Legendre, Jean-Philippe Lucot, Isabelle Matheron, Pierre Panel, Cyril Raiffort, Arnaud Fauconnier

Abstract

Background: Incomplete spontaneous abortions are defined by the intrauterine retention of the products of conception after their incomplete or partial expulsion. This condition may be managed by expectant care, medical treatment or surgery. Vacuum aspiration is currently the standard surgical treatment in most centers. However, operative hysteroscopy has the advantage over vacuum aspiration of allowing the direct visualization of the retained conception product, facilitating its elective removal while limiting surgical complications. Inadequately powered retrospective studies reported subsequent fertility to be higher in patients treated by operative hysteroscopy than in those treated by vacuum aspiration. These data require confirmation in a randomized controlled trial comparing fertility rates between women undergoing hysteroscopy and those undergoing vacuum aspiration for incomplete spontaneous abortion.

Methods: After providing written informed consent, 572 women with incomplete spontaneous abortion recruited from 15 centers across France will undergo randomization by a centralized computer system for treatment by either vacuum aspiration or operative hysteroscopy. Patients will not be informed of the type of treatment that they receive and will be cared for during their hospital stay in accordance with standard practices at each center. The patients will be monitored for pregnancy or adverse effects by a telephone conversation or questionnaire sent by e-mail or post over a period of two years. In cases of complications, failure of the intervention or diagnosis of uterine cavity disease, patient care will be left to the discretion of the medical center team.

Discussion: If our hypothesis is confirmed, this study will provide evidence that the use of operative hysteroscopy can increase the number of pregnancies continuing beyond 22 weeks of gestation in the two-year period following incomplete spontaneous abortion without increasing the incidence of morbidity and peri- and postoperative complications. The standard surgical treatment of this condition would thus be modified. This study would therefore have a large effect on the surgical management of incomplete spontaneous abortion.

Trial registration: ClinicalTrials.gov Identifier: NCT02201732 ; registered on 17 July 2014.

Figures

Fig. 1
Fig. 1
Patient flow chart

References

    1. Smith LF, Ewings PD, Quinlan C. Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long-term follow-up of miscarriage treatment (MIST) randomised controlled trial. BMJ. 2009;339:b3827. doi: 10.1136/bmj.b3827.
    1. Sur SD, Raine-Fenning NJ. The management of miscarriage. Best Pract Res Clin Obstet Gynaecol. 2009;23(4):479–91. doi: 10.1016/j.bpobgyn.2009.01.014.
    1. Torre A, Huchon C, Bussieres L, Machevin E, Camus E, Fauconnier A. Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial. Am J Obstet Gynecol. 2012;206(3):215. doi: 10.1016/j.ajog.2011.12.009.
    1. Friedler S, Margalioth EJ, Kafka I, Yaffe H. Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy − a prospective study. Hum Reprod. 1993;8(3):442–4.
    1. Golan A, Schneider D, Avrech O, Raziel A, Bukovsky I, Caspi E. Hysteroscopic findings after missed abortion. Fertil Steril. 1992;58(3):508–10.
    1. Westendorp IC, Ankum WM, Mol BW, Vonk J. Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod. 1998;13(12):3347–50. doi: 10.1093/humrep/13.12.3347.
    1. Faivre E, Deffieux X, Mrazguia C, Gervaise A, Chauveaud-Lambling A, Frydman R, et al. Hysteroscopic management of residual trophoblastic tissue and reproductive outcome: a pilot study. J Minim Invasive Gynecol. 2009;16(4):487–90. doi: 10.1016/j.jmig.2009.04.011.
    1. Golan A, Dishi M, Shalev A, Keidar R, Ginath S, Sagiv R. Operative hysteroscopy to remove retained products of conception: novel treatment of an old problem. J Minim Invasive Gynecol. 2011;18(1):100–3. doi: 10.1016/j.jmig.2010.09.001.
    1. Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014;173:19–22. doi: 10.1016/j.ejogrb.2013.11.020.
    1. Cohen SB, Kalter-Ferber A, Weisz BS, Zalel Y, Seidman DS, Mashiach S, et al. Hysteroscopy may be the method of choice for management of residual trophoblastic tissue. J Am Assoc Gynecol Laparosc. 2001;8(2):199–202. doi: 10.1016/S1074-3804(05)60577-4.
    1. Rein DT, Schmidt T, Hess AP, Volkmer A, Schöndorf T, Breidenbach M. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol. 2011;18(6):774–8. doi: 10.1016/j.jmig.2011.08.003.
    1. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96. doi: 10.1097/SLA.0b013e3181b13ca2.
    1. Salomon LJ, Nassar M, Bernard JP, Ville Y, Fauconnier A. Société Française pour l’Amélioration des Pratiques Echographiques (SFAPE). A score-based method to improve the quality of emergency gynaecological ultrasound examination. Eur J Obstet Gynecol Reprod Biol. 2009;143(2):116–20. doi: 10.1016/j.ejogrb.2008.12.003.
    1. Mol BW, van Der Veen F, Bossuyt PM. Implementation of probabilistic decision rules improves the predictive values of algorithms in the diagnostic management of ectopic pregnancy. Hum Reprod. 1999;14(11):2855–62. doi: 10.1093/humrep/14.11.2855.
    1. Bouquier J, Fauconnier A, Fraser W, Dumont A, Huchon C. Diagnosis of pelvic inflammatory disease. Which clinical and paraclinical criteria? Role of imaging and laparoscopy? J Gynecol Obstet Biol Reprod. 2012;41(8):835–49. doi: 10.1016/j.jgyn.2012.09.016.
    1. Ankum WM, Wieringa-De Waard M, Bindels PJ. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ. 2001;322(7298):1343–6. doi: 10.1136/bmj.322.7298.1343.
    1. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial) BMJ. 2006;332(7552):1235–40. doi: 10.1136/bmj.38828.593125.55.
    1. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81. doi: 10.1080/01621459.1958.10501452.
    1. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163–70.
    1. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41. doi: 10.1093/biomet/69.1.239.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere